Minority Owned Cannabis Company, TheraTrue Inc., Announces New CEO Victor Mancebo
Friday, February 26th, 2021
Today, TheraTrue, Inc., a minority owned medical cannabis production company, announced the addition of cannabis industry veteran Victor E. Mancebo as the company’s Chief Executive Officer. In addition, TheraTrue has received $50 million in funding commitments and submitted medical cannabis license applications in Georgia. This application marks the first major action of TheraTrue Inc. in the medical cannabis industry. TheraTrue is committed to using extensive research and cutting-edge technology to provide vertically integrated production facilities designed to safely deliver medical grade cannabis products to patients in Georgia.
“The TheraTrue team is driven by a focus on science and innovation to develop world-class medical products and treatments for the qualified patients in Georgia, a role that Victor has proven to be able to do successfully.” said TheraTrue’s founder Dr. Paul Judge. “As the company’s founder, I am keenly aware of the history of cannabis and how it has disproportionately impacted black Americans. We believe that it is important for the African American community to be represented in the cannabis industry and that we embrace diversity in ownership, leadership, and those we intend to treat.”
“I am beyond thrilled to join the TheraTrue team and lead our historic journey into the cannabis industry,” said Victor E. Mancebo, CEO of TheraTrue. “I believe that TheraTrue’s strategy of focusing on new medical markets with limited licenses is key to long term success. Our team is uniquely positioned to deploy key initiatives into these emerging markets, and provide Georgia’s medically qualified patients with consistent, quality, medical grade cannabis derived products.”
In Georgia, TheraTrue applied for a Medical Cannabis Production License with intention to establish its facilities in Louisville, located in Jefferson County. Georgia made the production of medical grade pharmaceutical medication containing low levels of THC to treat specific medical conditions for patients registered with the state’s Low THC Registry legal in 2019.
For media inquiries, contacts or questions, please email [email protected].